Interview with Ron Herings about big data in healthcare.
Ron Herings van PHARMO over big data
Ron Herings van PHARMO over big data
Renal function, estimated by different measures of eGFR, is not associated with serious bleeding events
Longer exposure to HbA1c levels above target (i.e. HbA1c ≥64 mmol/mol (8%)) is associated with
A strong decrease in the use of cyproterone acetate (CPA) 2 mg, in combination with
PHARMO’s annual scientific report discusses the current expertise and research of the PHARMO Institute, publications,
Metformin is the most common initial type 2 diabetes (T2DM) treatment in the Netherlands, Italy,
Research confirms: concerns were justified Today the results of the study into the consequences of
In the current issue: A validated algorithm for asthma and COPD, ISO certificates for PHARMO and
Only 67% of high-cardiovascular-risk patients are treated with lipid-modifying therapy (LMT), of which only 7%
The reduction in HbA1c is greater in patients starting basal insulin or insulin glargine compared